鶹ý

FDA Probes LAAO; Dairy Fat's Heart Benefit; Repatha OK'd for Pediatric HeFH

— Recent developments of interest in cardiovascular medicine

MedpageToday
Electrocardiogram on top and bottom of image with CardioBreak in the center.

In response to a study , FDA is investigating whether after Watchman left atrial appendage occlusion (LAAO) than men.

Shorter intervals between measurements: a way to standard protocol for automated office-based blood pressure evaluation. (Hypertension)

Transcatheter aortic valve replacement (TAVR) performed well as an alternative to surgery for aortic stenosis patients with a . (JACC: CardioOncology)

Female operators accounted for performed in 2018, and there were 19 U.S. states with no women performing these procedures that year, according to a report in Circulation: Cardiovascular Interventions.

Surgery appears to be underused in elderly people with . (Journal of the American Heart Association)

A simpler way to check for the enhanced ventricular interdependence characteristic of in the cardiac cath lab? (JAMA Cardiology)

The greater the , the lower the risk of incident cardiovascular disease, a meta-analysis showed. (PLOS Medicine)

for cardiovascular benefit in patients with type 2 diabetes? (Annals of Internal Medicine)

Researchers identified five predictors of mortality in thrombosis with thrombocytopenia syndrome . (European Heart Journal)

FDA approved PCSK9 inhibitor evolocumab (Repatha) as an adjunct to other lipid-lowering therapies for the treatment of , Amgen announced.

Also approved are Abbott's stented tissue valves for mitral or aortic valve replacement surgery.

Baxter says its ready-to-use is also FDA approved.

A coroner determined the cause of death for a teenage football player who died during a game and tested positive for SARS-CoV-2: , not COVID-19. (CBS Philly)

appeared to be a problem for older women and younger men in particular. (Hypertension)

In newly diagnosed pulmonary arterial hypertension, patients fared similarly on as they did on double oral therapy in the TRITON trial. (Journal of the American College of Cardiology)

People who are may be particularly vulnerable to developing cardiovascular disease, according to proteomic analysis. (ESPE Abstracts)

Tracking how many individuals, who are seropositive for T. cruzi, . (Circulation)

Low-income Asian countries saw diagnostic cardiovascular procedure volumes during the COVID-19 pandemic. (JACC: Asia)

Randomized study supports , who saw improvements in cardiovascular risk factors after a year. (Clinical Pediatrics)

Notable cardiologist and proponent of precision medicine Euan Ashley, MB, ChB, DPhil, of Stanford University in California, shared what he learned . (The Times)

Can inhibition of transcription factor TFAP2A be a treatment for ? (Science Translational Medicine)

  • author['full_name']

    Nicole Lou is a reporter for 鶹ý, where she covers cardiology news and other developments in medicine.